Feasibility studies of concomitant administration of optimized formulation of probiotic-loaded Vancomycin hydrochloride pellets for colon delivery

References

• Philip AK, Dabas S, Pathak K. Optimized prodrug approach: a means for achieving enhanced anti-inflammatory potential in experimentally induced colitis. J Drug Target 2009;17:235–41
   PubMed Web of Science ®Google Scholar
• Odeku OA, Fell JT. In-vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon. J Pharm Pharmacol 2005;57:163–8
   PubMed Web of Science ®Google Scholar
• Kulthe SS, Bahekar JJ, Godhani CC, et al. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach. Drug Dev Ind Pharm 2013;39:138–45
   PubMed Web of Science ®Google Scholar
• Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci 2003:6:33–66
   PubMed Web of Science ®Google Scholar
• Sarasija S, Hota A. Colon specific drug delivery systems. Ind J Pharm Sci 2000;62:1–8
   Google Scholar
• Elkhodairy K, Afifi SA, Zakaria AS. A promising approach to provide appropriate colon target drug delivery systems of vancomycin HCl: pharmaceutical and microbiological studies. Bio Med Res Int 2014. [Epub ahead of print]. doi: http://dx.doi.org/10.1155/2014/182197
   Google Scholar
• Buts JP, Bernasconi P. S.b. basic science and clinical applications in gastroenterology. Gasteroenterol Clin North Am 2005;34:515–32
   PubMed Web of Science ®Google Scholar
• Fietto JL, Araujo RS, Valasao FN, et al. Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 2004;50:615–21
   PubMed Web of Science ®Google Scholar
• VANCOMYCIN HCl. (Monographs for Professional). FDA and PI. Available from: http://www.drugs.com [last accessed 4 Feb 2015]
   Google Scholar
• Scott Dorfner. Patent WO 2011044208A1, antibiotic formulations providing reduced gastrointestinal side effects. 2011
   Google Scholar
• Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. OMJ 2010;25:70–8
   Google Scholar
• Yang L, James S, Joseph A. Colon specific drug delivery new approaches and in vitro/ in vivo evaluation. Int J Pharm 2002;23:1–15
   Web of Science ®Google Scholar
• Nath B, Nath LK. Formulation development and in-vitro/in-vivo correlation for a novel sterculia gum-based oral colon-targeted drug delivery system of azathioprine. Drug Dev Ind Pharm 2013;39:138–45
   PubMed Web of Science ®Google Scholar
• Bendas ER, Christensen JM, Ayres JW. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets colon targeting. Drug Dev Ind Pharm 2010;36:393–404
   PubMed Web of Science ®Google Scholar
• Akhgari A, Sadeghi F, Garekani HA. Combination of time dependent and pH dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm 2006;320:137–42
   PubMed Web of Science ®Google Scholar
• Bora PS, Puri V, Bansal AK. Physicochemical properties and excipient compatibility studies of probiotic Bacillus coagulans spores. Sci Pharm 2009;77:625–37
   Google Scholar
• Ella K, Vellimedu S. Patent US 20080226614A1, eukaryotic based synergistic formulation for gastro-intestinal disorders. 2004
   Google Scholar
• Sandrine G, Hussain S, Chaumeil JC, Charrueau C. Increased intestinal delivery of viable S.b. microencapsulation of microspheres. Pharm Res 2008;25:1290–8
   PubMed Web of Science ®Google Scholar
• Klayraung S, Viernstein H, Okonogi S. Development of tablets containing probiotics: effects of formulation and processing parameters on bacterial viability. Int J Pharm 2009;370:54–60
   PubMed Web of Science ®Google Scholar
• Gao C, Huang J, Jiao Y, et al. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30D-coated pellets. Int J Pharm 2006;322:104–12
   PubMed Web of Science ®Google Scholar
• Gupta VK, Beckert TE, Price JC. A novel pH- and time-based multi-unit potential colonic drug delivery system development. Int J Pharm 2001;213:83–91
   PubMed Web of Science ®Google Scholar
• Lai H, Lin K, Zhang W, et al. Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation. Drug Dev Ind Pharm 2011;37:1347–56
   PubMed Web of Science ®Google Scholar
• Ibekwe VC, Fadda HM, Parsons GE, Basit AW. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. Int J Pharm 2006;308:52–60
   PubMed Web of Science ®Google Scholar
• Valizadeh H, Milani PZ, Loveymi BD, Jelvehgari M. The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system. Colloids Surf B 2013;103:174–81
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Mahzouni P, Dorkoosh F. Development of novel budesonide pellets based on CODES™ technology: in vitro/in vivo evaluation in induced colitis in rats. Daru 2011;19:107–18
   PubMed Web of Science ®Google Scholar
• Katsuma M, Watanabe S, Kawai H, et al. Studies on lactulose formulations for colon-specific drug delivery. Int J Pharm 2002;249:33–43
   PubMed Web of Science ®Google Scholar
• Lai H, Zhu F, Yuan W, et al. Development of multiple-unit colon-targeted drug delivery system by using alginate: in vitro and in vivo evaluation. Drug Dev Ind Pharm 2011;37:1347–56
   PubMed Web of Science ®Google Scholar
• Asghar L, Chandran S. Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J Pharm Pharm Sci 2006;9:327–38
   PubMed Web of Science ®Google Scholar
• Kramer A, Turk S, Vrecer F. Statistical optimization of diclofenac sodium sustained release pellets coated with polymethacrylic films. Int J Pharm 2003;256:43–52
   PubMed Web of Science ®Google Scholar